Preclinical screening for retinopathy of prematurity risk using IGF1 levels at 3 weeks post-partum

Alejandro Pérez-Muñuzuri1, Maria Luz Couce-Pico1, Ana Baña-Souto1

  • 1Neonatology Service, Department of Paediatrics, Clinical Hospital of the University of Santiago de Compostela, Santiago de Compostela, Spain.

Plos One
|February 14, 2014
PubMed

Insights

Measuring serum IGF1 levels and sepsis presence in premature infants can predict retinopathy of prematurity (ROP). This screening helps identify high-risk newborns for better ROP prediction and resource optimization.

Area of Science:

  • Neonatology
  • Ophthalmology
  • Pediatric Critical Care

Background:

  • Current retinopathy of prematurity (ROP) prevention requires extensive patient screening.
  • Identifying high-risk infants for ROP is crucial for effective resource allocation.

Purpose of the Study:

  • To develop a predictive screening system for retinopathy of prematurity (ROP).
  • To determine key biomarkers for early ROP risk assessment in premature infants.

Main Methods:

  • Prospective study of 145 premature newborns (<1500g birthweight or <32 weeks gestational age).
  • Analysis of clinical variables including serum IGF1 levels at week 3 and sepsis presence.
  • Multiple logistic regression used to identify significant risk factors for ROP.

Main Results:

  • 26.9% of enrolled infants developed some form of retinopathy.
  • Significant associations found between ROP and gestational age, birthweight, mechanical ventilation, oxygen, intracranial hemorrhage, sepsis, BPD, transfusions, erythropoietin, and low IGF1.
  • Serum IGF1 levels and sepsis presence showed high predictive value for ROP.

Conclusions:

  • Serum IGF1 levels and sepsis are strong predictors of ROP development.
  • This preclinical screening method can identify high-risk infants, improving ROP prediction.
  • Optimized screening enhances the efficient use of clinical resources for ROP management.

Related Concept Videos